MEDICINE CORRECTION OF ABDOMINAL ADIPOSITY INDICES IN PATIENTS WITH CHRONIC PANCREATITIS

Abstract

The problem of chronic pancreatitis and comorbid obesity is very relevant today. In daily practice, the physician has a question about choice an effective treatment scheme for such patients.

The aim of the study – to learn the efficacy of inclusion to standard therapy metadoxine (Liveria IC) on abdominal adiposity indices.

Material and Methods. 100 patients with chronic biliary pancreatitis and obesity were examined. The patients were divided into 2 groups. The group 1 (45 persons) received a general treatment (GT). The group 2 (55 persons) received metadoxine in the complex to GT. The following indices were used to determine abdominal obesity: WHR, WTR, WAR and WHtR.

Results and Discussion. After the treatment, the positive dynamic of abdominal obesity indices was observed in both groups. But, inclusion metadoxine to GT contributed significant higher effectiveness of treatment.

The WHR indicator was lower on 13.3 % in group 2 compared to the same group 1, WTR – 15.4 %, WAR – 14.0 %, WHtR – 16.2 %, respectively. Data in the group 2 were statistically significant for those in group 1 after the treatment (p<0.05).

Conclusion. Application to the complex treatment of metadoxine (Liveria IC) contributed significant increase the effectiveness of treatment abdominal adiposity indices in patients with chronic biliary pancreatitis.